United States Prostate Cancer Diagnostics Market Report & Forecast 2021-2027

United States Prostate Cancer Diagnostics Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Diagnostics Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Prostate Cancer Diagnostics Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Prostate Cancer Diagnostics Overall Market Size
2.1 United States Prostate Cancer Diagnostics Market Size: 2021 VS 2027
2.2 United States Prostate Cancer Diagnostics Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Diagnostics Players in United States Market
3.2 Top United States Prostate Cancer Diagnostics Companies Ranked by Revenue
3.3 United States Prostate Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Diagnostics Companies in United States Market, by Revenue in 2020
3.5 Companies Prostate Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Diagnostics Players in United States Market
3.6.1 List of Tier 1 Prostate Cancer Diagnostics Companies in United States
3.6.2 List of Tier 2 and Tier 3 Prostate Cancer Diagnostics Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Prostate Cancer Diagnostics Market Size Markets, 2021 & 2027
4.1.2 Tumor Biomarker Tests
4.1.3 Imaging
4.1.4 Biopsy
4.1.5 Other
4.2 By Type - United States Prostate Cancer Diagnostics Revenue & Forecasts
4.2.1 By Type - United States Prostate Cancer Diagnostics Revenue, 2016-2021
4.2.2 By Type - United States Prostate Cancer Diagnostics Revenue, 2022-2027
4.2.3 By Type - United States Prostate Cancer Diagnostics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Prostate Cancer Diagnostics Market Size, 2021 & 2027
5.1.2 Age Below 55
5.1.3 Age 55-75
5.1.4 Age Above 75
5.2 By Application - United States Prostate Cancer Diagnostics Revenue & Forecasts
5.2.1 By Application - United States Prostate Cancer Diagnostics Revenue, 2016-2021
5.2.2 By Application - United States Prostate Cancer Diagnostics Revenue, 2022-2027
5.2.3 By Application - United States Prostate Cancer Diagnostics Revenue Market Share, 2016-2027
6 Prostate Cancer Diagnostics Companies Profiles
6.1 OPKO
6.1.1 OPKO Company Details
6.1.2 OPKO Business Overview
6.1.3 OPKO Prostate Cancer Diagnostics Introduction
6.1.4 OPKO Prostate Cancer Diagnostics Revenue in United States Market (2016-2021)
6.1.5 OPKO Recent Developments
6.2 Genomic Health
6.2.1 Genomic Health Company Details
6.2.2 Genomic Health Business Overview
6.2.3 Genomic Health Prostate Cancer Diagnostics Introduction
6.2.4 Genomic Health Prostate Cancer Diagnostics Revenue in United States Market (2016-2021)
6.2.5 Genomic Health Recent Developments
6.3 Abbott
6.3.1 Abbott Company Details
6.3.2 Abbott Business Overview
6.3.3 Abbott Prostate Cancer Diagnostics Introduction
6.3.4 Abbott Prostate Cancer Diagnostics Revenue in United States Market (2016-2021)
6.3.5 Abbott Recent Developments
6.4 Beckman Coulter
6.4.1 Beckman Coulter Company Details
6.4.2 Beckman Coulter Business Overview
6.4.3 Beckman Coulter Prostate Cancer Diagnostics Introduction
6.4.4 Beckman Coulter Prostate Cancer Diagnostics Revenue in United States Market (2016-2021)
6.4.5 Beckman Coulter Recent Developments
6.5 Siemens Healthcare
6.5.1 Siemens Healthcare Company Details
6.5.2 Siemens Healthcare Business Overview
6.5.3 Siemens Healthcare Prostate Cancer Diagnostics Introduction
6.5.4 Siemens Healthcare Prostate Cancer Diagnostics Revenue in United States Market (2016-2021)
6.5.5 Siemens Healthcare Recent Developments
6.6 bioMeriux
6.6.1 bioMeriux Company Details
6.6.2 bioMeriux Business Overview
6.6.3 bioMeriux Prostate Cancer Diagnostics Introduction
6.6.4 bioMeriux Prostate Cancer Diagnostics Revenue in United States Market (2016-2021)
6.6.5 bioMeriux Recent Developments
6.7 Roche
6.7.1 Roche Company Details
6.7.2 Roche Business Overview
6.7.3 Roche Prostate Cancer Diagnostics Introduction
6.7.4 Roche Prostate Cancer Diagnostics Revenue in United States Market (2016-2021)
6.7.5 Roche Recent Developments
6.8 MDx Health
6.8.1 MDx Health Company Details
6.8.2 MDx Health Business Overview
6.8.3 MDx Health Prostate Cancer Diagnostics Introduction
6.8.4 MDx Health Prostate Cancer Diagnostics Revenue in United States Market (2016-2021)
6.8.5 MDx Health Recent Developments
6.9 DiaSorin
6.9.1 DiaSorin Company Details
6.9.2 DiaSorin Business Overview
6.9.3 DiaSorin Prostate Cancer Diagnostics Introduction
6.9.4 DiaSorin Prostate Cancer Diagnostics Revenue in United States Market (2016-2021)
6.9.5 DiaSorin Recent Developments
6.10 Myriad Genetics
6.10.1 Myriad Genetics Company Details
6.10.2 Myriad Genetics Business Overview
6.10.3 Myriad Genetics Prostate Cancer Diagnostics Introduction
6.10.4 Myriad Genetics Prostate Cancer Diagnostics Revenue in United States Market (2016-2021)
6.10.5 Myriad Genetics Recent Developments
6.11 Ambry Genetics
6.11.1 Ambry Genetics Company Details
6.11.2 Ambry Genetics Business Overview
6.11.3 Ambry Genetics Prostate Cancer Diagnostics Introduction
6.11.4 Ambry Genetics Prostate Cancer Diagnostics Revenue in United States Market (2016-2021)
6.11.5 Ambry Genetics Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Prostate Cancer Diagnostics Market Opportunities & Trends in United States Market
Table 2. Prostate Cancer Diagnostics Market Drivers in United States Market
Table 3. Prostate Cancer Diagnostics Market Restraints in United States Market
Table 4. Key Players of Prostate Cancer Diagnostics in United States Market
Table 5. Top Prostate Cancer Diagnostics Players in United States Market, Ranking by Revenue (2019)
Table 6. United States Prostate Cancer Diagnostics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. United States Prostate Cancer Diagnostics Revenue Share by Companies, 2016-2021
Table 8. Companies Prostate Cancer Diagnostics Product Type
Table 9. List of Tier 1 Prostate Cancer Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Prostate Cancer Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - United States Prostate Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - United States Prostate Cancer Diagnostics Revenue (US$, Mn), 2016-2021
Table 13. By Type - United States Prostate Cancer Diagnostics Revenue (US$, Mn), 2022-2027
Table 14. By Application - United States Prostate Cancer Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - United States Prostate Cancer Diagnostics Revenue (US$, Mn), 2016-2021
Table 16. By Application - United States Prostate Cancer Diagnostics Revenue (US$, Mn), 2022-2027
Table 17. OPKO Company Details
Table 18. OPKO Business Overview
Table 19. OPKO Prostate Cancer Diagnostics Product
Table 20. OPKO Prostate Cancer Diagnostics Revenue in United States Market (2016-2021) & (US$ Million)
Table 21. OPKO Recent Developments
Table 22. Genomic Health Company Details
Table 23. Genomic Health Business Overview
Table 24. Genomic Health Prostate Cancer Diagnostics Product
Table 25. Genomic Health Prostate Cancer Diagnostics Revenue in United States Market (2016-2021) & (US$ Million)
Table 26. Genomic Health Recent Developments
Table 27. Abbott Company Details
Table 28. Abbott Business Overview
Table 29. Abbott Prostate Cancer Diagnostics Product
Table 30. Abbott Prostate Cancer Diagnostics Revenue in United States Market (2016-2021) & (US$ Million)
Table 31. Abbott Recent Developments
Table 32. Beckman Coulter Company Details
Table 33. Beckman Coulter Business Overview
Table 34. Beckman Coulter Prostate Cancer Diagnostics Product
Table 35. Beckman Coulter Prostate Cancer Diagnostics Revenue in United States Market (2016-2021) & (US$ Million)
Table 36. Beckman Coulter Recent Developments
Table 37. Siemens Healthcare Company Details
Table 38. Siemens Healthcare Business Overview
Table 39. Siemens Healthcare Prostate Cancer Diagnostics Product
Table 40. Siemens Healthcare Prostate Cancer Diagnostics Revenue in United States Market (2016-2021) & (US$ Million)
Table 41. Siemens Healthcare Recent Developments
Table 42. bioMeriux Company Details
Table 43. bioMeriux Business Overview
Table 44. bioMeriux Prostate Cancer Diagnostics Product
Table 45. bioMeriux Prostate Cancer Diagnostics Revenue in United States Market (2016-2021) & (US$ Million)
Table 46. bioMeriux Recent Developments
Table 47. Roche Company Details
Table 48. Roche Business Overview
Table 49. Roche Prostate Cancer Diagnostics Product
Table 50. Roche Prostate Cancer Diagnostics Revenue in United States Market (2016-2021) & (US$ Million)
Table 51. Roche Recent Developments
Table 52. MDx Health Company Details
Table 53. MDx Health Business Overview
Table 54. MDx Health Prostate Cancer Diagnostics Product
Table 55. MDx Health Prostate Cancer Diagnostics Revenue in United States Market (2016-2021) & (US$ Million)
Table 56. MDx Health Recent Developments
Table 57. DiaSorin Company Details
Table 58. DiaSorin Business Overview
Table 59. DiaSorin Prostate Cancer Diagnostics Product
Table 60. DiaSorin Prostate Cancer Diagnostics Revenue in United States Market (2016-2021) & (US$ Million)
Table 61. DiaSorin Recent Developments
Table 62. Myriad Genetics Company Details
Table 63. Myriad Genetics Business Overview
Table 64. Myriad Genetics Prostate Cancer Diagnostics Product
Table 65. Myriad Genetics Prostate Cancer Diagnostics Revenue in United States Market (2016-2021) & (US$ Million)
Table 66. Myriad Genetics Recent Developments
Table 67. Ambry Genetics Company Details
Table 68. Ambry Genetics Business Overview
Table 69. Ambry Genetics Prostate Cancer Diagnostics Product
Table 70. Ambry Genetics Prostate Cancer Diagnostics Revenue in United States Market (2016-2021) & (US$ Million)
Table 71. Ambry Genetics Recent Developments
List of Figures
Figure 1. Prostate Cancer Diagnostics Segment by Type
Figure 2. Prostate Cancer Diagnostics Segment by Application
Figure 3. United States Prostate Cancer Diagnostics Market Overview: 2020
Figure 4. United States Prostate Cancer Diagnostics Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. United States Prostate Cancer Diagnostics Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Prostate Cancer Diagnostics Revenue in 2020
Figure 7. By Type - United States Prostate Cancer Diagnostics Revenue Market Share, 2016-2027
Figure 8. By Application - United States Prostate Cancer Diagnostics Revenue Market Share, 2016-2027
Figure 9. OPKO Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Genomic Health Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Abbott Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Beckman Coulter Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Siemens Healthcare Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. bioMeriux Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Roche Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. MDx Health Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. DiaSorin Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Myriad Genetics Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Ambry Genetics Prostate Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Prostate Cancer Diagnostics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Prostate Cancer Diagnostics market size was valued at US$ 13140 million in 2023. With growing demand in downstream market, the Prostate Cancer Diagnostics is forecast to a readjusted size of US$ 22650 million by 2030 with a CAGR of 8.1% during review period. The research report highlights the growth potential of the global Prostate Cancer Diagnostics market. Prostate Cancer Diagnostics are expected to show stable growth in th......

Global Checkpoint Inhibitors for Treating Cancer Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 83

According to our LPI (LP Information) latest study, the global Checkpoint Inhibitors for Treating Cancer market size was valued at US$ 12220 million in 2023. With growing demand in downstream market, the Checkpoint Inhibitors for Treating Cancer is forecast to a readjusted size of US$ 63530 million by 2030 with a CAGR of 26.6% during review period. The research report highlights the growth potential of the global Checkpoint Inhibitors for Treating Cancer market. Checkpoint Inhibitors for......

Global PSA Test Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 111

According to our LPI (LP Information) latest study, the global PSA Test market size was valued at US$ 499.9 million in 2023. With growing demand in downstream market, the PSA Test is forecast to a readjusted size of US$ 861.8 million by 2030 with a CAGR of 8.1% during review period. The research report highlights the growth potential of the global PSA Test market. PSA Test are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global HPV Testing Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 87

According to our LPI (LP Information) latest study, the global HPV Testing market size was valued at US$ 784.6 million in 2023. With growing demand in downstream market, the HPV Testing is forecast to a readjusted size of US$ 1398.7 million by 2030 with a CAGR of 8.6% during review period. The research report highlights the growth potential of the global HPV Testing market. HPV Testing are expected to show stable growth in the future market. However, product differentiation, reducing cos......

Global Prostate Cancer Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 102

According to our (Global Info Research) latest study, the global Prostate Cancer Diagnostics market size was valued at USD 13820 million in 2023 and is forecast to a readjusted size of USD 22870 million by 2030 with a CAGR of 7.5% during review period. The prostate is a walnut-sized gland located behind the base of a man's penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be ......

Global Pap Tests and HPV Tests Market Research Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 130

The Pap test (or Pap smear) looks for precancers, cell changes on the cervix that might become cervical cancer if they are not treated appropriately. The HPV test looks for the virus (human papillomavirus) that can cause these cell changes. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can......

Global Pap Tests and HPV Tests Professional Survey Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 3280 Onwards        Pages: 106

The Pap test (or Pap smear) looks for precancers, cell changes on the cervix that might become cervical cancer if they are not treated appropriately. The HPV test looks for the virus (human papillomavirus) that can cause these cell changes. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can......

Global Checkpoint Inhibitors For Treating Cancer Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 102

Market Overview of Global Checkpoint Inhibitors For Treating Cancer market: According to our latest research, the global Checkpoint Inhibitors For Treating Cancer market looks promising in the next 5 years. As of 2022, the global Checkpoint Inhibitors For Treating Cancer market was estimated at USD 18595.4 million, and it's anticipated to reach USD 42557.61 million in 2028, with a CAGR of 14.8% during the forecast years. Checkpoint inhibitor is a type of drug used in immunoth......

Global Solid Tumor Testing Professional Survey Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 100

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs